Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in <i>MET</i> -Amplified Esophagogastric CancerEunice L. Kwak, Ryan B. Corcoran, Darrell R. Borger et al.|Cancer Discovery|2015Cited by 168
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i> V600E Colorectal CancerMehlika Hazar-Rethinam, Ryan B. Corcoran, Marianna Kleyman et al.|Cancer Discovery|2018Cited by 73